|
By
Dr. Artemis P. Simopoulos
Over the past 20
years many studies and clinical investigations have been carried
out on the metabolism of polyunsaturated fats in general and
on omega-3 fats in particular.
Today we know that
omega-3 fats are essential for normal growth and development
and may play an important role in the prevention and treatment
of coronary artery disease, hypertension, diabetes, arthritis,
other inflammatory and autoimmune disorders, and cancer (1-7).
Research has been
done in animal models, tissue cultures, and human beings.
The original observational studies have given way to controlled
clinical trials. Great progress has taken place in our knowledge
of the physiologic and molecular mechanisms of the various
fats in health and disease. Specifically, their beneficial
effects have been shown in the prevention and management of:
- Coronary heart
disease (8, 9),
- Hypertension
(10-12)
- Type 2 diabetes
(13, 14)
- Renal disease
(15, 16)
- Rheumatoid
arthritis (17)
- Ulcerative
colitis (18)
- Crohn disease
(19)
- Chronic obstructive
pulmonary disease (20)
However, this
review focuses on the evolutionary aspects of diet, the biological
effects of omega-6 and omega-3 fats, and the effects of dietary
-linolenic acid (ALA) compared with long-chain omega-3 derivatives
on coronary heart disease and diabetes.
Essential Fats Such As Omega-6
And Omega-3 Have Been Part Of Our Diet Since The Beginning
Of Human Life
Before the agricultural revolution 10,000 years ago humans
consumed about equal amounts of both. Over the past 150 years
this balance has been upset. Current estimates in Western
cultures suggest a ratio
of omega-6 to omega-3 fats of 10-20:1 instead of 1-4:1.
On the basis of estimates from studies in Paleolithic nutrition
and modern-day hunter-gatherer populations, it appears that
human beings evolved consuming a diet that was much lower
in saturated fats than is today's diet (21).
Furthermore, the diet contained small and roughly equal amounts
of omega-6 and omega-3 PUFAs (ratio of 1-2:1) and much lower
amounts of trans fats than does today's diet (21, 22). The
current Western diet is very high in omega-6 fats (the ratio
of omega-6 to omega-3 fats is 20-30:1) because of the indiscriminate
recommendation to substitute omega-6 fats for saturated fats
to lower serum cholesterol concentrations (23).
Intake of omega-3 fats is much lower today because of the
decrease in fish consumption and the industrial production
of animal feeds rich in grains containing omega-3 fats, leading
to production of meat rich in omega-6 and poor in omega-3
fats (24). The same is true for cultured fish (25) and eggs
(26).
Even cultivated vegetables contain fewer omega-3 fats than
do plants in the wild (27, 28). In summary, modern agriculture,
with its emphasis on production, has decreased the omega-3
fat content in many foods: green leafy vegetables, animal
meats, eggs, and even fish.
Biological Effects of Omega-6
and Omega-3 Fats
Linoleic acid and alpha linolenic acid ALA and their long-chain
derivatives are important components of animal and plant cell
membranes. When you eat fish or fish oil, the EPA and DHA
partially replace the omega-6 fats especially arachidonic
acid in cell membranes.
As a result eating EPA and DHA from fish or fish oil leads
to:
1) Decreased
concentrations of thromboxane A2, a potent platelet aggregator
and vasoconstrictor;
2) Decreased formation of leukotriene B4, an inducer of
inflammation and a powerful inducer of leukocyte chemotaxis
and adherence;
3) Increased concentrations of thromboxane A3, a weak platelet
aggregator and vasoconstrictor;
4) Increased concentrations of prostacyclin PGI3, leading
to an overall increase in total prostacyclin by increasing
PGI3 without decreasing PGI2 (both PGI2 and PGI3 are active
vasodilators and inhibitors of platelet aggregation); and
6) Increased concentrations of leukotriene B5, a weak inducer
of inflammation and chemotactic agent (29, 30).
Because of the
increased amounts of omega-6 fats in the Western diet, the
eicosanoid metabolic products from arachadonic acid, specifically
prostaglandins, thromboxanes, leukotrienes, hydroxy fats,
and lipoxins, are formed in larger quantities than those formed
from omega-3 fats, specifically EPA.
A diet rich in omega-6 fats shifts the physiologic state to
one that is prothrombotic and proaggregatory, with increases
in blood viscosity, vasospasm, and vasoconstriction and decreases
in bleeding time.
The higher the ratio of
omega-6 to omega-3 fats the higher is the death rate from
cardiovascular disease (33). As the ratio of omega-6
to omega-3 increases, the prevalence of type 2 diabetes also
increases (13).
Effects of Dietary Flax Compared
With Fish Oil
ALA, found in flax seed is the precursor of omega-3 fats,
can be converted to long-chain omega-3 fats and can therefore
be substituted for fish oils.
However, ALA is not equivalent in its biological effects to
the long-chain omega-3 fats found in marine oils. EPA and
DHA are more rapidly incorporated into plasma and membrane
lipids and produce more rapid effects than does ALA.
Experimental studies suggest that intake of 3-4
grams of ALA per day is equivalent to 0.3 grams (300 mg) EPA
per day.
Relatively large reserves of LA in body fat, as are found
in vegans or in the diet of omnivores in Western societies,
would tend to slow down the formation of long-chain omega-3
fats like EPA and DHA from ALA.
One advantage of the consumption of ALA over omega-3 fats
from fish is that the problem of insufficient vitamin E intake
does not exist with high intake of ALA from plant sources.
Benefits of Omega-3 Fats
Dietary intake of omega-3 fats from seafood was associated
with reduced risk of primary cardiac arrest compared with
no fish intake; 5.5 g omega-3 fats per month or the equivalent
of 1 fatty fish meal per week was associated with a 50% reduction
in the risk of primary cardiac arrest.
A 5.0% increase in omega-3 fats was associated with a 70%
reduction in the risk of primary cardiac arrest.
An increase in EPA and DHA also leads to increases in membrane
fluidity, the number of insulin receptors, and insulin action.
Clinical interventions provide further support for the beneficial
effects of omega-3 fats in the prevention and management of
cardiovascular disease, hyperinsulinemia, and possibly type
2 diabetes.
Omega-3 fats affect coronary heart disease beneficially not
by changing serum lipid concentrations, although EPA and DHA
do lower triglycerides, by reducing blood clotting in vessel
walls (72, 76) and ventricular arrhythmias (8, 9, 75, 77).
Am.
J. Clinical Nutrition, September 1999; 70: 560 - 569
References
|